Order Article Reprints

Liao C-H, Yen C-C, Chen H-L, Liu Y-H, Chen Y-H, Lan Y-W, Chen K-R, Chen W, Chen C-M. Novel Kefir Exopolysaccharides (KEPS) Mitigate Lipopolysaccharide (LPS)-Induced Systemic Inflammation in Luciferase Transgenic Mice through Inhibition of the NF-κB Pathway. Antioxidants. 2023; 12(9):1724. https://doi.org/10.3390/antiox12091724

Liao, Chun-Huei, Chih-Ching Yen, Hsiao-Ling Chen, Yu-Hsien Liu, Yu-Hsuan Chen, Ying-Wei Lan, Ke-Rong Chen, Wei Chen, and Chuan-Mu Chen. 2023. "Novel Kefir Exopolysaccharides (KEPS) Mitigate Lipopolysaccharide (LPS)-Induced Systemic Inflammation in Luciferase Transgenic Mice through Inhibition of the NF-κB Pathway" Antioxidants 12, no. 9: 1724. https://doi.org/10.3390/antiox12091724

Liao, C.-H., Yen, C.-C., Chen, H.-L., Liu, Y.-H., Chen, Y.-H., Lan, Y.-W., Chen, K.-R., Chen, W., & Chen, C.-M. (2023). Novel Kefir Exopolysaccharides (KEPS) Mitigate Lipopolysaccharide (LPS)-Induced Systemic Inflammation in Luciferase Transgenic Mice through Inhibition of the NF-κB Pathway. Antioxidants, 12(9), 1724. https://doi.org/10.3390/antiox12091724